Bausch Health
BHC
#3604
Rank
C$4.07 B
Marketcap
$11.10
Share price
2.00%
Change (1 day)
7.22%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$3.61

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$3.60. In 2022 the company made an earnings per share (EPS) of -$0.84 an increase over its 2021 EPS that were of -$3.61.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.61328.29%
2022-$0.84-76.64%
2021-$3.6168.45%
2020-$2.14-68.91%
2019-$6.88-57.11%
2018-$16.05-272.22%
2017$9.32-199.29%
2016-$9.39798.7%
2015-$1.04-128.31%
2014$3.69-204.62%
2013-$3.53602.7%
2012-$0.50-171.15%
2011$0.71-143.96%
2010-$1.60-206.57%
2009$1.51-11.2%
2008$1.702.46%
2007$1.65-7.58%
2006$1.79-14.29%
2005$2.0954%
2004$1.36-500%
2003-$0.34-141.67%
2002$0.81-4.76%
2001$0.85-175%
2000-$1.14-268%
1999$0.6814.94%
1998$0.5920.83%
1997$0.4953.83%
1996$0.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.36-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.37-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA